AC Immune (ACIU) EBIT Margin Growth (3y) (2018 - 2025)

AC Immune (ACIU) EBIT Margin Growth (3y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -204.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 828,504.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 7,261.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -50,506.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -2,649.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 9,003.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 30,461.00
10 AC Immune 253.89 Mn 253.89 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.92 Mn
Sep 30, 2025 -137,641.00
Dec 31, 2022 -5.12 Mn
Sep 30, 2022 -116,234.00
Dec 31, 2020 -214,991.00
Sep 30, 2020 -85,523.00
Mar 31, 2020 41,329.00
Dec 31, 2019 -310,418.00
Sep 30, 2019 143,837.00
Mar 31, 2019 126,784.00
Dec 31, 2018 -130,896.00
Sep 30, 2018 -60,732.00